mission, overcomes this problem. [14] [15] [16] The statistic for mine; DRD4; genetics this family-based association design is the haplotype
Previously in this journal, we reported an association relative risk (HRR) contingency coefficient.
of the dopamine D4 receptor gene (DRD4) and attention
In the present study, we used a family-based deficit hyperactivity disorder (ADHD). In a populationapproach [12] [13] [14] [15] [16] to replicate and extend our initial study We were able to obtain blood samples, extract DNA In recent investigations of genetic etiologies of and obtain DRD4 genotypes from 136 parents and from ADHD, 1 we have focused on the coding region of the 105 probands. In 75 of these families, we could deduce DRD4 gene located on chromosome 11p.
2 This is a pritransmission of the DRD4 alleles from 127 parents to mary candidate gene for association with ADHD for the 75 probands. In 52 of these families, we had comseveral reasons. First, the most common treatments plete information on both parents as well as the profor ADHD are the stimulant medications band (ie, the DRD4 alleles of trios for the HRR (methylphenidate, amphetamine, and pemoline) that analysis). As shown in Table 1 , the percentage of 7 act primarily on the dopamine system, implicating repeat alleles in the probands (29/104 = 28%) was DRD4 and other dopamine genes. Second, DRD4 disabout the same as in our prior sample (23/78 = 29%). Also, the percentage of probands with a 7+ genotype plays a high degree of variability in the third cytoplas- basal ganglia dopamine pathways 9, 17, 18 and may be associated with personality traits (eg, novelty seeking) that contribute to the manifestation of ADHD. [5] [6] [7] However, the candidate gene approach we used and our focus on the DRD4 gene would not detect the contributions of other genes. We have taken the first steps to (25/52 = 48%) was about the same as in our prior sample (19/39 = 49%).
investigate other dopamine genes, 19 including the dopamine transporter gene (DAT1), which Cook et al 20 We also show in Table 1 the allele frequencies and percentages for alleles in the parents, as well as for the and Gill et al 21 found to be associated with ADHD, and the dopamine D2 receptor gene (DRD2), which Comtheoretical controls derived by subtraction of the allele frequencies of the probands from the allele frequencies ings et al 22 found to be associated with ADHD and many other psychiatric disorders. In our studies based of the parents. In this family-based association study, this 'control' group does not provide an estimate of on the refined phenotype of ADHD described here, we have not found significant association with the DAT1 population allele frequency, but instead provides a control for population stratification that may be present and DRD2 genes. 19 This may be due to our use of a refined phenotype of ADHD (based on the absence of in the sample.
In our family-based association design, the HRR comorbid conditions and the presence of clinical response to methylphenidate), to our use of an inadanalysis of parent-to-proband allele transmission provides a test for association of an allele (7 repeat) with equate sample size, or to other factors. In the next step in our research program, we intend to identify affected a disorder (ADHD), and the parental alleles are the focus of analysis. [12] [13] [14] [15] [16] The frequencies and percentages relatives and use a genome scan design 23 to identify other genes that may be associated and linked to our of the observed allele pairs from the 104 parental chromosomes, with transmission (t) and non-transmission refined phenotype of ADHD. We are also aware that ADHD may have non-genetic (nt) noted, are shown in Table 2 .
From the frequencies in Table 2 , the HRR statistic as well as genetic etiologies. In fact, in adoption 24 and family 25 studies of ADHD, models have been conwas calculated using the method described by Ewen and Spielman. 12 The '4n' transmitted and non-transstructed that indicate a high phenocopy rate and suggest that in clinical samples about half of the cases may mitted alleles from the parents of the 'n' trios were used to form Table 3 . The HRR contingency statistic be phenocopies and not have a genetic basis for the disorder. It has been suggested that environmentally-[HRR = 4n(w−y) 2 /((w+y)(4n−w−y))] was significant (chi-square = 4.65, d.f. = 1, P Ͻ 0.035). altered brain development due to fetal distress, which selectively damages dopamine neurons 26 and affects Only 50% of our ADHD probands had a 7 repeat allele of the DRD4 gene, so this is not a necessary concortical-basal ganglia dopamine pathways, 27,28 may increase risk for behavioral symptoms of ADHD. We dition for the diagnosis of ADHD. As discussed in the introduction, we have focused on the DRD4 gene hypothesize that similar biological consequences (eg, underactivity in cortical-basal ganglia neural networks) because of the plausible hypothesis that the 7 repeat allele may encode a subsensitive form of the DRD4 may occur due to genetic factors (eg, inheritance of a 30 diagnosis of Hyperkinetic Disorder (HKD), the DISC interview was documented by ratings of the and the term ADHD/HKD has been suggested to ident-DSM-IV symptoms on the SNAP rating scale 35 comify the subset of ADHD cases who also meet HKD cripleted by teachers as well as parents of the probands. teria. 31 The ADHD/HKD phenotype is based on diverBetween May 1996 and August 1997, 813 families sity of symptoms (cases with fewer than six inattention were screened and 191 met the entry criteria for parsymptoms, three hyperactivity symptoms, and one ticipation in our clinical trials program. By September impulsivity symptom are excluded, so many of the 1997, 119 of these families participated in assessment cases with the Primarily Inattentive or Primarily phases of a clinical trial and agreed to participate in Hyperactive/Impulsive subtypes specified in DSM-IV this separate genetic study. We were able to obtain a do not meet these refined diagnostic criteria) and an blood sample and extract DNA from 105 probands and absence of comorbid disorders (ADHD cases with con-136 parents. In this sample, the average number of current diagnosis of anxiety, depression, pervasive symptoms endorsed on the DISC was 7.8 from the Inatdevelopmental or Tourette's disorder are excluded, so tention domain and 7.5 from the many of the comorbid subgroups allowed in DSM-IV Hyperactive/Impulsive domain. The average initial do not meet these refined diagnostic criteria).
dose of methylphenidate was 14.5 mg, the average Also, we should emphasize that we continued to number of administrations per day was 2.3, and the limit our studies to children being treated with stimuaverage daily dose was 28.9 mg. The percentage of prolant medication and manifesting a beneficial clinical bands with ADHD combined type was 82%, and 47% response. As recently confirmed by anatomical brain also met DSM-IV criteria for Oppositional Defiant Disimaging, 32 the requirement of a beneficial response to order. We excluded cases with a primary diagnosis of stimulant medication may identify a group of ADHD comorbid Tourette's Disorder, Conduct Disorder, Anxicases with reduced size of the executive control neural ety Disorder, Mood Disorder, or Pervasive Developnetwork defined by Posner and Raichle. 33 This network mental Disorder. is localized to anterior cingulate and basal ganglia brain regions 9, 17, [31] [32] [33] where D4 receptors may be concentrated. 8 
Genetic
In summary, the data from this study provide Blood samples were obtained when families were additional evidence that the DRD4 gene is associated being seen at the UCI Child Development Center. These with a refined phenotype of ADHD. Despite the samples were sent to the Clarke Institute of Psychiatry, improvement in methodology provided by the familyToronto, Canada for DNA extraction. Within 3 days, based association design, our findings still need to be genomic DNA was extracted from whole blood by saltreplicated in independent and larger samples. We recing out. The amplification of the 48-base pair repeat ommend that the refined phenotype of ADHD, which region of DRD4 was performed as described by Lichter we used in our present study and our prior study, 1 be et al. 36 PCR products were separated in 3.5% agarose considered in attempts to replicate our finding of an gels prepared with ethidium bromide and electrophorassociation of the DRD4 gene with ADHD.
esed in 1× TBE (0.089 M Tris, 0.089 M boric acid, 0.002 M EDTA Na 2 ). Methods
Clinical
Statistical ADHD probands were recruited for participation in a Genotypes were obtained from available DNA of proclinical trial being conducted at the UC Irvine Child bands and parents, and transmission of alleles from Development Center and sponsored by ALZA Corporparent to proband was determined for 75 probands. In ation or Richwood Pharmaceuticals. The criteria for 52 of these families, genotypes were obtained on trios eligibility included a confirmed diagnosis of ADHD of the proband and both parents. The HRR test was and absence of comorbid diagnoses of anxiety, mood used to calculate a within-family contingency statistic disorder, pervasive developmental disorder, conduct based on the alleles of the 'n' (52) trios. The '2n' transdisorder, Tourette's disorder, or other conditions mitted alleles, consisting of 'w' 7+ alleles and '2n − 2' requiring separate, non-stimulant pharmacological 7-alleles, and the '2n' non-transmitted alleles, contreatment or special placement in school due to sisting of 'y' 7+ alleles and '2n − (2n − y)' 7-alleles, extremely aggressive behavior. These diagnostic criwere used to calculate the within-family contingency teria were documented by structured interview with coefficient by the following formula: HRR = the Diagnostic Interview Schedule for Children (DISC). 34 The age at assessment was between 7 and 12 4n(w−y) 2 /[(w+y)(4n−w−y)].
